Perspectives of application of intranasally administered insulin for correction of metabolic and hormonal disorders in diabetes mellitus and metabolic syndrome

Cover Page
Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access


In recent years, the possibility of using intranasally administered insulin to treat Alzheimer’s disease and other cognitive disorders has been widely studied. At the same time, the possibility of its use in the treatment of diabetes mellitus is practically not investigated, which is due to the insufficient study of the molecular mechanisms of its action on the hormonal and metabolic status of the organism. The review discusses literature data and the results of our own research on the role of insulin in the central regulation of energy homeostasis, as well as on the experience of using intranasally administered insulin to correct eating disorders and metabolic and hormonal dysfunctions developing under conditions of experimental diabetes mellitus and metabolic syndrome. In studies involving healthy volunteers, various effects of intranasally administered insulin were shown, including effects on cognitive function, eating behavior and weight loss, and the gender specificity of its action was found. In the course of numerous studies of intranasally administered insulin in animal models of diabetes mellitus, not only stabilization of carbohydrate homeostasis was shown, but also a positive effect in the form of restoration of the functional activity of insulin signaling pathways in the hypothalamus and other parts of the brain. We have presented and analyzed data on the systemic effects of intranasally administered insulin in rodents with experimental models of diabetes mellitus, as well as in healthy individuals.

Full Text

Restricted Access

About the authors

Alexander O. Shpakov

Sechenov Institute of Evolutionary Physiology and Biochemistry of Russian Academy of Sciences

ORCID iD: 0000-0002-4293-3162
SPIN-code: 6335-8311
Scopus Author ID: 35231150500

Russian Federation, 44, Thorez prospekt, St.-Petersburg, 194223


Kira V. Derkach

Sechenov Institute of Evolutionary Physiology and Biochemistry of Russian Academy of Sciences

ORCID iD: 0000-0001-6555-9540
SPIN-code: 6925-1558
Scopus Author ID: 6603743572

Russian Federation, 44, Thorez prospekt, St.-Petersburg, 194223


Elena V. Surkova

Endocrinology Research Centre

ORCID iD: 0000-0002-3973-7638
SPIN-code: 7944-3869
Scopus Author ID: 6602194740

Russian Federation, 11, Dm. Ulyanova street, Moscow, 117036


Alexey I. Bespalov

Endocrinology Research Centre

Author for correspondence.
ORCID iD: 0000-0003-1584-5690
SPIN-code: 9466-2528

Russian Federation, 11, Dm. Ulyanova street, Moscow, 117036



  1. Shpakov AO, Derkach KV. Gormonal’nye sistemy mozga i sakharnyy diabet 2-go tipa. Saint-Petersburg: Izdatel’stvo Politekhnicheskogo universiteta; 2015.
  2. Gizurarson S, Bechgaard E. Intranasal administration of insulin to humans. Diabetes Res Clin Pract. 1991;12(2):71-84. doi:
  3. Hirai S, Ikenaga T, Matsuzawa T. Nasal Absorption of Insulin in Dogs. Diabetes. 1978;27(3):296-299 doi:
  4. Frauman A, Buchanan R, Jerumus G, Louis W. Intranasal insulin (INI) treatment of type I diabetes: clinical and immunologic effects using two different absorption enhancing adjuvants. Diabetes Res Clin Pract. 1988;5(Suppl 1):S162.
  5. Derkach KV, Ivantsov AO, Chistyakova OV, et al. Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome. Biull Eksp Biol Med. 2017;163(2):144-149.
  6. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29-38. doi:
  7. Baskin D. Insulin In The Brain. Annu Rev Physiol. 1987;49(1):335-347. doi:
  8. Porte Jr D, Seeley RJ, Woods SC, et al. Obesity, diabetes and the central nervous system. Diabetologia. 1998;41(8):863-881. doi:
  9. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Med. 2002;8(12):1376-1382. doi:
  10. Hallschmid M, Benedict C, Schultes B, et al. Intranasal Insulin Reduces Body Fat in Men but not in Women. Diabetes. 2004;53(11): 3024-3029. doi:
  11. Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nature Neuroscience. 2002;5(6):514-516. doi:
  12. Clegg DJ, Riedy CA, Smith KAB, et al. Differential Sensitivity to Central Leptin and Insulin in Male and Female Rats. Diabetes. 2003;52(3):682-687. doi:
  13. Hallschmid M, Benedict C, Schultes B, et al. Obese men respond to cognitive but not to catabolic brain insulin signaling. Int J Obes (Lond). 2008;32(2):275-282. doi:
  14. Jauch-Chara K, Friedrich A, Rezmer M, et al. Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans. Diabetes. 2012;61(9):2261-2268. doi:
  15. Kenny PJ. Reward mechanisms in obesity: new insights and future directions. Neuron. 2011;69(4):664-679. doi:
  16. Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011;15(1):37-46. doi:
  17. Appelhans BM. Neurobehavioral inhibition of reward-driven feeding: implications for dieting and obesity. Obesity (Silver Spring). 2009;17(4):640-647. doi:
  18. Lathe R. Hormones and the hippocampus. J Endocrinol. 2001; 169(2):205-231. doi:
  19. Figlewicz DP, Szot P, Chavez M, et al. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res. 1994;644(2):331-334. doi:
  20. Guthoff M, Grichisch Y, Canova C, et al. Insulin modulates food-related activity in the central nervous system. J Clin Endocrinol Metab. 2010;95(2):748-755. doi:
  21. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal Hormones Determine Sensitivity to Central Leptin and Insulin. Diabetes. 2006;55(4):978-987. doi:
  22. Krug R, Benedict C, Born J, Hallschmid M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. J Clin Endocrinol Metab. 2010;95(12):E468-472. doi:
  23. Hallschmid M, Higgs S, Thienel M, et al. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes. 2012;61(4):782-789. doi:
  24. Koch L, Wunderlich FT, Seibler J, et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118(6):2132-2147. doi:
  25. Heni M, Wagner R, Kullmann S, et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes. 2014;63(12):4083-4088. doi:
  26. Dash S, Xiao C, Morgantini C, et al. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations. Diabetes. 2015;64(3):766-774. doi:
  27. Chen M, Woods SC, Porte D. Effect of Cerebral Intraventricular Insulin on Pancreatic Insulin Secretion in the Dog. Diabetes. 1975;24(10):910-914. doi:
  28. Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab. 2012;16(4):500-510. doi:
  29. Chaiken RL, Moses AC, Silver RD, et al. The Prolonged Hypoglycemic Effect Of An Insulin-Adjuvant Nasal Spray In Diabetes Is Secondary To Prolonged Suppression Of Hepatic Glucose Output. Clin Res. 1985;33(2):A426.
  30. Shpakov AO, Moyseyuk IV, Chistyakova OV, et al. Treatment with intranasal insulin and serotonin restores the sensitivity of adenylyl cyclase to hormone in the brain of rats with long-term neonatal diabetes mellitus. Biulletenʹ FTSSKE im. V.A. Almazova. 2013;(1):21-27.
  31. Shpakov A, Chistyakova O, Derkach K, et al. Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes. Open Life Sci. 2012;7(1). doi:
  32. Shpakov AO, Derkach KV, Chistyakova OV, et al. Effect of intranasal insulin and serotonin on functional activity of the adenylyl cyclase system in myocardium, ovary, and uterus of rats with prolonged neonatal model of diabetes mellitus. Zh Evol Biokhim Fiziol. 2013;49(2):118-127.
  33. Sukhov IB, Derkach KV, Chistyakova OV, et al. Functional state of hypothalamic signaling systems in rats with type 2 diabetes mellitus treated with intranasal insulin. Zh Evol Biokhim Fiziol. 2016;52(3):184-194.
  34. Kuznetsova LA, Plesneva SA, Sharova TS, et al. Attenuation of inhibitory influence of hormones on adenylyl cyclase systems in the myocardium and brain of obese and type 2 diabetic rats as affected by the intranasal insulin treatment. Zh Evol Biokhim Fiziol. 2014;50(5):349-357.
  35. Kuznetsova LA, Sharova TS, Pertseva MN, Shpakov AO. Beta-adrenergic regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin administration. Zh Evol Biokhim Fiziol. 2015;51(3):170-180.
  36. Shpakov AO, Chistyakova OV, Derkach KV, et al. Activity of receptor guanylyl cyclases in rats with neonatal streptozotocin diabetes and effect of intranasal administration of insulin and serotonin. Cell and Tissue Biology. 2011;53(7):591-599.
  37. Chistyakova OV, Sukhov IB, Shipilov VN, et al. Vliyanie intranazal’nogo vvedeniya insulina i serotonina na kognitivnye protsessy u krys s eksperimental’nym sakharnym diabetom 2-go tipa. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. 2010;8(1):M75
  38. Kuznetsova LA, Derkach KV, Sharova TS, et al. The activity of no-synthases in the brain, myocardium and skeletal muscles of obese rats and the influence of long-term treatment with intranasal insulin. Translational medicine. 2015;(1):39-45.
  39. Derkach KV, Ignat’eva PA, Shpakov AO. Hormonal regulation of adenylyl cyclase in the myocardium of male rats with metabolic syndrome and the influence of treatment with metformin and intranasally administered insulin. Translational medicine. 2016;3(1):73-81. doi: 10.18705/2311-4495-2016-3-1-73-81
  40. Shpakov AO. Functional activity of the brain insulin signaling system in norm and in type 2 diabetes mellitus. Russian journal of physiology. 2015;101(10):1103-1127.
  41. Shpakov AO, Derkach KV. The Melanocortin Signal System of the Hypothalamus and Its Functional State in Type 2 Diabetes Mellitus and Metabolic Syndrome. Russian journal of physiology. 2017;103(5):504-517.
  42. Sukhov IB, Shipilov VN, Chistyakova OV, et al. Long-term intranasal insulin administration improves spatial memory in male rats with prolonged type 1 diabetes mellitus and in healthy rats. Dokl Akad Nauk. 2013;453(5):577. doi: 10.7868/S0869565213350272
  43. Derkach KV, Bogush IV, Berstein LM, Shpakov AO. The Influence of Intranasal Insulin on Hypothalamic-Pituitary-Thyroid Axis in Normal and Diabetic Rats. Horm Metab Res. 2015;47(12):916-924. doi:

Supplementary files

There are no supplementary files to display.



Abstract - 467

PDF (Russian) - 1

Remote (Russian) - 373




Copyright (c) 2020 Shpakov A.O., Derkach K.V., Surkova E.V., Bespalov A.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies